Pharmacokinetics of single-dose intravenous amikacin in critically ill patients undergoing slow hemodialysis
- 1 April 1995
- journal article
- research article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 21 (4) , 348-351
- https://doi.org/10.1007/bf01705414
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A Serial Application Study on Twice Daily Dose of Imipenem/Cilastatin in Patients Undergoing Slow HemodialysisNephron, 1994
- Slow Hemodialysis Performed during the Day in Managing Renal Failure in Critically III PatientsNephron, 1994
- Removal of imipenem and cilastatin by hemodialysis in patients with end-stage renal failureAntimicrobial Agents and Chemotherapy, 1991
- Pharmacokinetics of amikacin during continuous veno-venous hemofiltrationCritical Care Medicine, 1990
- Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activityAntimicrobial Agents and Chemotherapy, 1990
- Changes of the Serum Amikacin (AMK) Level in Patients with Serious Acute Renal Failure Treated by Continuous Arteriovenous Hemofiltration (CAVH)Artificial Organs, 1989
- Randomized Trials of Aminoglycoside Antibiotics: Quantitative OverviewClinical Infectious Diseases, 1988
- Pharmacokinetics of Amikacin During Hemodialysis and Peritoneal DialysisAntimicrobial Agents and Chemotherapy, 1977
- Pharmacokinetics of Amikacin in Patients with Normal or Impaired Renal Function: Radioenzymatic Acetylation AssayThe Journal of Infectious Diseases, 1976
- Activity of BB-K8 (Amikacin) Against Clinical Isolates Resistant to One or More Aminoglycoside AntibioticsAntimicrobial Agents and Chemotherapy, 1974